TTKHLTCARE

TTK Healthcare Limited

Diversified consumer and healthcare products company with veterinary products and medical devices

Diversified›Diversified›Diversified›Diversified

ttkhealthcare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1035.00
Market cap
1,462 Cr
Stock P/E
19.8
P/B
1.31
Dividend yield
1.0%
ROE (FY26)
5.9%
ROCE (FY26)
7.5%
Operating margin (FY26)
2.0%
Debt / equity (FY26)
0.02
OCF / EBITDA (FY26)
-80.8%
OCF / EBITDA (3Y)
-30.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

TTK Healthcare is a Chennai-based diversified maker of consumer products (including Woodward's Gripe Water), veterinary products, medical devices such as heart valves and orthopaedic implants, male contraceptives and food products.

Company snapshot

5thBy market cap

Ranked among 6 companies in Diversified.

Segment mix

Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.

Largest segment: 31.4% of revenue

SegmentRevenue shareRevenuePBTAssets
ANIMAL WELFARE
15.7%
96 Cr8 Cr—
CONSUMER PRODUCTS
31.4%
192 Cr21 Cr—
FOODS
15.8%
97 Cr3 Cr—
MEDICAL DEVICES
11.1%
68 Cr16 Cr—
OTHERS
0.0%
0.24 Cr0.25 Cr—
PROTECTIVE DEVICES
26.0%
159 Cr-4 Cr—

What we see

Positives
  • ✓Debt-to-equity of 0.02x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales186 Cr184 Cr181 Cr208 Cr198 Cr205 Cr190 Cr226 Cr204 Cr209 Cr218 Cr258 Cr
Operating expenses (approx.)176 Cr179 Cr169 Cr201 Cr190 Cr197 Cr178 Cr224 Cr198 Cr202 Cr207 Cr243 Cr
EBITDA10 Cr5 Cr12 Cr7 Cr8 Cr8 Cr12 Cr3 Cr5 Cr7 Cr11 Cr15 Cr
OPM %5.1%2.9%6.9%3.3%4.1%3.8%6.3%1.2%2.6%3.4%5.1%5.7%
Other income16 Cr16 Cr16 Cr17 Cr18 Cr18 Cr19 Cr18 Cr19 Cr17 Cr18 Cr17 Cr
Interest0.73 Cr0.23 Cr0.93 Cr0.86 Cr0.74 Cr0.82 Cr0.90 Cr0.77 Cr0.84 Cr0.68 Cr0.64 Cr0.53 Cr
Depreciation3 Cr3 Cr3 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Profit before tax22 Cr18 Cr24 Cr41 Cr23 Cr23 Cr22 Cr18 Cr21 Cr14 Cr30 Cr29 Cr
Tax %25.7%27.1%24.6%22.6%25.8%25.9%25.8%26.4%4.3%25.2%26.3%26.3%
Net profit16 Cr13 Cr18 Cr32 Cr17 Cr17 Cr16 Cr13 Cr20 Cr11 Cr22 Cr21 Cr
EPS (₹)₹11.33₹9.13₹12.93₹22.35₹12.17₹11.84₹11.43₹9.20₹14.43₹7.45₹15.40₹15.06

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales528 Cr578 Cr628 Cr646 Cr637 Cr599 Cr725 Cr753 Cr801 Cr857 CrSign in free for the trailing twelve months
Operating expenses (approx.)489 Cr535 Cr578 Cr617 Cr602 Cr577 Cr694 Cr715 Cr767 Cr831 CrSign in free for the trailing twelve months
EBITDA38 Cr43 Cr50 Cr28 Cr35 Cr22 Cr31 Cr37 Cr35 Cr26 CrSign in free for the trailing twelve months
OPM %7.3%7.4%7.9%4.4%5.5%3.6%4.3%5.0%4.3%3.1%Sign in free for the trailing twelve months
Other income6 Cr8 Cr8 Cr9 Cr10 Cr16 Cr48 Cr63 Cr71 Cr72 CrSign in free for the trailing twelve months
Interest3 Cr5 Cr3 Cr3 Cr2 Cr3 Cr5 Cr3 Cr3 Cr3 CrSign in free for the trailing twelve months
Depreciation12 Cr15 Cr15 Cr14 Cr14 Cr13 Cr13 Cr13 Cr8 Cr9 CrSign in free for the trailing twelve months
Profit before tax29 Cr30 Cr39 Cr19 Cr37 Cr58 Cr838 Cr84 Cr108 Cr83 CrSign in free for the trailing twelve months
Tax %35.8%39.7%37.9%36.6%-25.3%28.0%23.7%25.3%24.6%20.4%Sign in free for the trailing twelve months
Net profit19 Cr18 Cr24 Cr12 Cr46 Cr42 Cr640 Cr63 Cr82 Cr66 CrSign in free for the trailing twelve months
EPS (₹)₹24.13₹12.86₹17.25₹8.72₹32.87₹29.43₹452.72₹44.47₹57.79₹46.48Sign in free for the trailing twelve months
Dividend payout %————9.1%20.4%2.2%22.5%17.3%21.5%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital8 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr
Reserves150 Cr219 Cr237 Cr235 Cr281 Cr316 Cr939 Cr987 Cr1,051 Cr1,101 Cr
Borrowings23 Cr47 Cr28 Cr28 Cr18 Cr20 Cr26 Cr21 Cr24 Cr24 Cr
Other liabilities105 Cr127 Cr136 Cr154 Cr182 Cr209 Cr191 Cr178 Cr192 Cr190 Cr
Total liabilities285 Cr407 Cr416 Cr431 Cr494 Cr559 Cr1,170 Cr1,201 Cr1,281 Cr1,329 Cr
Fixed assets (net)99 Cr109 Cr97 Cr88 Cr85 Cr80 Cr71 Cr75 Cr81 Cr73 Cr
CWIP0.25 Cr0.79 Cr2 Cr9 Cr0.45 Cr0.19 Cr3 Cr0.79 Cr0.08 Cr1 Cr
Investments9 Cr9 Cr13 Cr9 Cr13 Cr15 Cr13 Cr13 Cr11 Cr9 Cr
Inventories44 Cr53 Cr55 Cr72 Cr70 Cr79 Cr85 Cr97 Cr109 Cr109 Cr
Trade receivables34 Cr55 Cr80 Cr77 Cr60 Cr54 Cr92 Cr86 Cr91 Cr111 Cr
Cash & bank19 Cr15 Cr11 Cr8 Cr10 Cr15 Cr9 Cr11 Cr9 Cr22 Cr
Other assets80 Cr165 Cr157 Cr169 Cr256 Cr316 Cr897 Cr918 Cr981 Cr1,005 Cr
Total assets285 Cr407 Cr416 Cr431 Cr494 Cr559 Cr1,170 Cr1,201 Cr1,281 Cr1,329 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity18 Cr25 Cr17 Cr20 Cr96 Cr45 Cr-26 Cr-5 Cr-4 Cr-21 Cr
Cash from investing5 Cr-23 Cr10 Cr-13 Cr-77 Cr-31 Cr33 Cr28 Cr20 Cr52 Cr
Cash from financing-23 Cr-7 Cr-31 Cr-10 Cr-17 Cr-9 Cr-12 Cr-22 Cr-18 Cr-18 Cr
Net cash flow0.13 Cr-4 Cr-4 Cr-4 Cr2 Cr5 Cr-6 Cr2 Cr-2 Cr13 Cr
Free cash flow (OCF − Capex)12 Cr21 Cr13 Cr8 Cr95 Cr39 Cr-38 Cr-15 Cr-17 Cr-27 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %17.9%12.5%15.2%8.2%12.6%17.4%86.1%8.5%10.3%7.5%
ROE %11.9%7.8%9.7%4.9%15.8%12.6%67.1%6.3%7.7%5.9%
Debtor days24354743343346424147
Inventory days339221199251259200169204202197
Days payable519361261303359262249215199166
Cash conversion cycle-156-105-16-9-66-30-34314479
OCF / EBITDA %46.3%59.5%34.9%70.1%276.4%206.1%-83.2%-13.2%-11.4%-80.8%
OCF / EBITDA % (3 years)——46.3%51.9%118.5%189.7%131.0%15.4%-33.8%-30.6%
Debt / equity0.150.200.110.110.060.060.030.020.020.02
Current ratio1.391.531.731.741.992.135.065.505.235.91
Net debt / EBITDA0.100.760.340.730.230.250.520.280.440.08